Amalgamated Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,251
| Closed | -$767K | – | 3063 |
|
|
2021
Q4 | $767K | Sell |
8,251
-31
| -0.4% | -$2.04K | 0.01% | 1367 |
|
|
2021
Q3 | $493K | Sell |
8,282
-591
| -7% | -$34.9K | ﹤0.01% | 1591 |
|
|
2021
Q2 | $605K | Buy |
8,873
+3,891
| +78% | +$254K | ﹤0.01% | 1521 |
|
|
2021
Q1 | $346K | Sell |
4,982
-382
| -7% | -$29.4K | 0.01% | 1192 |
|
|
2020
Q4 | $412K | Buy |
5,364
+13
| +0.2% | +$974 | 0.02% | 1070 |
|
|
2020
Q3 | $400K | Buy |
5,351
+154
| +3% | +$10.3K | 0.02% | 966 |
|
|
2020
Q2 | $327K | Sell |
5,197
-3,586
| -41% | -$197K | 0.02% | 1064 |
|
|
2020
Q1 | $369K | Sell |
8,783
-275
| -3% | -$12.6K | 0.01% | 1053 |
|
|
2019
Q4 | $411K | Buy |
9,058
+534
| +6% | +$25.2K | 0.01% | 1226 |
|
|
2019
Q3 | $390K | Sell |
8,524
-111
| -1% | -$6.24K | 0.01% | 1175 |
|
|
2019
Q2 | $506K | Buy |
8,635
+1,229
| +17% | +$63.5K | 0.01% | 1067 |
|
|
2019
Q1 | $332K | Buy |
7,406
+292
| +4% | +$13.4K | 0.01% | 1199 |
|
|
2018
Q4 | $277K | Buy |
+7,114
| New | +$279K | 0.01% | 1215 |
|
|
2018
Q3 | – | Sell |
-7,406
| Closed | -$323K | – | 1674 |
|
|
2018
Q2 | $323K | Buy |
7,406
+1,712
| +30% | +$73.6K | 0.01% | 1276 |
|
|
2018
Q1 | $225K | Buy |
+5,694
| New | +$221K | 0.01% | 1392 |
|
|
2017
Q2 | – | Sell |
-3,007
| Closed | -$44K | – | 1601 |
|
|
2017
Q1 | $44K | Sell |
3,007
-1
| -0% | -$15 | ﹤0.01% | 1474 |
|
|
2016
Q4 | $43K | Buy |
3,008
+405
| +16% | +$6.27K | ﹤0.01% | 1487 |
|
|
2016
Q3 | $46K | Buy |
2,603
+13
| +0.5% | +$216 | ﹤0.01% | 1363 |
|
|
2016
Q2 | $43K | Buy |
2,590
+37
| +1% | +$661 | ﹤0.01% | 1361 |
|
|
2016
Q1 | $50K | Buy |
2,553
+226
| +10% | +$3.62K | ﹤0.01% | 1256 |
|
|
2015
Q4 | $44K | Sell |
2,327
-200
| -8% | -$4.08K | 0.01% | 1173 |
|
|
2015
Q3 | $48K | Buy |
2,527
+23
| +0.9% | +$781 | 0.01% | 1263 |
|
|
2015
Q2 | $116K | Buy |
2,504
+74
| +3% | +$3.21K | 0.01% | 1296 |
|
|
2015
Q1 | $106K | Buy |
2,430
+285
| +13% | +$13.2K | 0.01% | 905 |
|
|
2014
Q4 | $74K | Buy |
2,145
+2
| +0.1% | +$81 | 0.01% | 835 |
|
|
2014
Q3 | $90K | Hold |
2,143
| – | – | 0.01% | 820 |
|
|
2014
Q2 | $126K | Buy |
2,143
+136
| +7% | +$8.56K | 0.02% | 844 |
|
|
2014
Q1 | $126K | Sell |
2,007
-19
| -0.9% | -$1.26K | 0.02% | 794 |
|
|
2013
Q4 | $119K | Buy |
+2,026
| New | +$106K | 0.02% | 797 |
|
Amalgamated Bank's ARNA Position: Q1 2022 in Review
Amalgamated Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 8,251 shares — an estimated $767K sold.
Amalgamated Bank first reported a position in ARNA in Q4 2013 and held it in 29 quarters. The position peaked at $767K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Amalgamated Bank reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Amalgamated Bank sold 8,251 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $767K.
- Amalgamated Bank first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 29 quarters.
- Amalgamated Bank's Arena Pharmaceuticals Inc position peaked at $767K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.